Review on Bosentan, A Dual Endothelin Receptor Antagonist for the Treatment of Pulmonary Arterial Hypertension

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 5, Iss. 3, 2010-01 ,pp. : 184-195

Bentham Science Publishers

Access to resources Recommend Favorite

ACUTE CARDIOPULMONARY EFFECTS OF A DUAL–ENDOTHELIN RECEPTOR ANTAGONIST ON OLEIC ACID–INDUCED PULMONARY ARTERIAL HYPERTENSION IN DOGS

By Wang Ling   Zhu Du   Su Xiao   Bai Chun   Ware Lorraine   Matthay Michael  

Experimental Lung Research, Vol. 30, Iss. 1, 2004-01 ,pp. : 31-42

Informa Healthcare

Access to resources Recommend Favorite

Clinical Pharmacotherapy and Drug Development for Pulmonary Arterial Hypertension

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 6, Iss. 3, 2011-09 ,pp. : 180-188

Bentham Science Publishers

Access to resources Recommend Favorite

Development of Monocrotaline-Induced Pulmonary Hypertension Is Attenuated by a Serotonin Receptor Antagonist

By Miyata M.   Ito M.   Sasajima T.   Ohira H.   Sato Y.   Kasukawa R.  

Lung, Vol. 178, Iss. 2, 2000-03 ,pp. : 63-73

Springer Publishing Company

Access to resources Recommend Favorite

Acute pulmonary arterial hypertension associated with anti-synthetase syndrome

By Taniguchi Y   Horino T   Kato T   Terada Y  

Scandinavian Journal of Rheumatology, Vol. 39, Iss. 2, 2010-03 ,pp. : 179-180

Informa Healthcare

Access to resources Recommend Favorite